Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.

ABSTRACT:

Background

COVID-19 is associated with higher morbidity and mortality in patients with chronic liver diseases (CLDs). However, our understanding of the long-term outcomes of COVID-19 in patients with CLD is limited.

Methods

We conducted a multicenter, observational cohort study of adult patients with CLD who were diagnosed with COVID-19 before May 30, 2020, to determine long-term clinical outcomes. We used a control group of patients with CLD confirmed negative for COVID-19.

Results

We followed 666 patients with CLD (median age 58 years, 52.8% male) for a median of 384 (interquartile range: 31-462) days. The long-term mortality was 8.1%; with 3.6% experiencing delayed COVID-19-related mortality. Compared to a propensity-matched control group of patients with CLD witho

SUBMITTER: Aby ES 

PROVIDER: S-EPMC9827967 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature